胶质母细胞瘤干细胞样细胞中印记DLK1-DIO3区域表达失调:lncRNA MEG3的抑癌作用
该研究探讨14q32印记DLK1-DIO3区域在胶质母细胞瘤(GBM)发病中的失调机制。在GBM干细胞样细胞(GSCs)和GBM组织中,该区域基因及非编码RNA表达缺失,主要由表观遗传沉默介导。MEG3和MEG8低表达与患者生存期短显著相关;恢复MEG3可抑制GSCs的体外生长、迁移和克隆形成,并减少体内肿瘤生长和浸润。
要点
- GBM中DLK1-DIO3区域基因及非编码RNA表达下调,以表观遗传沉默为主。
- MEG3和MEG8低表达与GBM患者生存期短显著相关。
- 恢复MEG3可抑制GSCs增殖、迁移、克隆形成及体内肿瘤生长和浸润。
核心结论
- 在GBM中,MEG3作为抑癌因子主要调控细胞黏附、上皮-间质转化(EMT)和细胞增殖,为GBM新疗法提供潜在靶点。
研究设计与样本
- 研究采用实时PCR分析GSCs和GBM组织,并用甲基化分析、基因表达和反相蛋白阵列图谱研究MEG3的抑癌功能。
主要发现
- 与正常脑组织相比,GSCs和GBM组织中DLK1-DIO3区域基因及非编码RNA表达缺失,该下调主要由表观遗传沉默介导。
- Kaplan-Meier分析显示,MEG3和MEG8长非编码RNA低表达与GBM患者生存期短显著相关。
- 恢复MEG3在体外通过抑制细胞生长、迁移和克隆形成削弱GSCs致瘤能力,并在体内减少肿瘤生长和浸润性生长。
- 上述效应与细胞黏附和EMT相关基因的调控有关。
临床怎么用
- MEG3和MEG8低表达可能作为GBM患者预后不良的分子标志物。
- 恢复MEG3功能或靶向其调控的黏附与EMT通路,可能成为GBM治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioblastoma (GBM) stemlike cells (GSCs) are thought to be responsible for the maintenance and aggressiveness of GBM, the most common primary brain tumor in adults. This study aims at elucidating the involvement of deregulations within the imprinted delta-like homolog 1 gene‒type III iodothyronine deiodinase gene (DLK-DIO3) region on chromosome 14q32 in GBM pathogenesis. METHODS: Real-time PCR analyses were performed on GSCs and GBM tissues. Methylation analyses, gene expression, and reverse-phase protein array profiles were used to investigate the tumor suppressor function of the maternally expressed 3 gene (MEG3). RESULTS: Loss of expression of genes and noncoding RNAs within the DLK1-DIO3 region was observed in GSCs and GBM tissues compared with normal brain. This downregulation is mainly mediated by epigenetic silencing. Kaplan-Meier analysis indicated that low expression of MEG3 and MEG8 long noncoding (lnc)RNAs significantly correlated with short survival in GBM patients. MEG3 restoration impairs tumorigenic abilities of GSCs in vitro by inhibiting cell growth, migration, and colony formation and decreases in vivo tumor growth, reducing infiltrative growth. These effects were associated with modulation of genes involved in cell adhesion and epithelial-to-mesenchymal transition (EMT). CONCLUSION: In GBM, MEG3 acts as a tumor suppressor mainly regulating cell adhesion, EMT, and cell proliferation, thus providing a potential candidate for novel GBM therapies.
引用
- Buccarelli M, Lulli V, Giuliani A, et al. Deregulated expression of the imprinted DLK1-DIO3 region in glioblastoma stemlike cells: tumor suppressor role of lncRNA MEG3. Neuro Oncol. 2020. PMID: 32459347. doi:10.1093/neuonc/noaa127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。